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The amount of each phospholipid (PL) standard stock solutions added to create the 
five synthetic PL mixtures.  
Table S1: Amount of each synthetic PL stock solutions added to create 2% synthetic PL 
mixtures. 
 
Table S2: Amount of each synthetic PL stock solutions added to create 4% synthetic PL 
mixtures.   
 
Table S3: Amount of each synthetic PL stock solutions added to create 6% synthetic PL 
mixtures.   
 
 
Synthetic PL standards  uMolar % total phospholipids 
PtdEtn 16:0/18:1 80.8 8.1 
PtdCho 16:0/18:1  363.8 36.4 
PtdCho 16:0/18:2 363.8 36.4 
PtdEtn 18:0/20:4 50.5 5.1 
PtdCho 16:0/20:4 101.1 10.1 
PtdEtn 18:0/22:6 8.0 0.8 
PtdCho 16:0/22:6 32.0 3.2 
Synthetic PL standards  uMolar % total phospholipids 
PtdEtn 16:0/18:1 77.5 7.7 
PtdCho 16:0/18:1  348.6 34.9 
PtdCho 16:0/18:2 348.6 34.9 
PtdEtn 18:0/20:4 48.4 4.8 
PtdCho 16:0/20:4 96.8 9.7 
PtdEtn 18:0/22:6 16.0 1.6 
PtdCho 16:0/22:6 64.0 6.4 
Synthetic PL standards  uMolar % total phospholipids 
PtdEtn 16:0/18:1 74.1 7.4 
PtdCho 16:0/18:1  333.5 33.3 
PtdCho 16:0/18:2 333.5 33.3 
PtdEtn 18:0/20:4 46.3 4.6 
PtdCho 16:0/20:4 92.6 9.3 
PtdEtn 18:0/22:6 24.0 2.4 
PtdCho 16:0/22:6 96.0 9.6 
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Table S4: Amount of each synthetic PL stock solutions added to create 8% synthetic PL 
mixtures.    
 
Table S5: Amount of each synthetic PL stock solutions added to create 10% synthetic PL 










Synthetic PL standards  uMolar % total phospholipids 
PtdEtn 16:0/18:1 70.7 7.1 
PtdCho 16:0/18:1  318.3 31.8 
PtdCho 16:0/18:2 318.3 31.8 
PtdEtn 18:0/20:4 44.2 4.4 
PtdCho 16:0/20:4 88.4 8.8 
PtdEtn 18:0/22:6 32.0 3.2 
PtdCho 16:0/22:6 128.0 12.8 
Synthetic PL standards  uMolar % total phospholipids 
PtdEtn 16:0/18:1 67.4 6.7 
PtdCho 16:0/18:1  303.2 30.3 
PtdCho 16:0/18:2 303.2 30.3 
PtdEtn 18:0/20:4 42.1 4.2 
PtdCho 16:0/20:4 84.2 8.4 
PtdEtn 18:0/22:6 40.0 4.0 
PtdCho 16:0/22:6 160.0 16.0 
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Example of the correction applied to 16:0, 18:0 and 18:1 concentration determined by 
GC. The example provided here is for 18:0 in a single sample. This procedure was 
repeated for 16:0, 18:0 and 18:1 in every sample.  
1) Determine the proportion of CerPCho 18:0 from MS data.  
     [CerPCho 18:0 (MS)] / [total 18:0 (MS)] = proportion of CerPCho 18:0 (MS) 
     (0.95 nmol/ml) / (6.91 nmol/ml) = 0.14 
2) Estimate the concentration of CerPCho 18:0 obtained by GC. 
0.14 X [18:0 (GC)] = [CerPCho 18:0 (GC)] 
            0.14 X 213.8 nmol/ml = 29.9 nmol/ml 
3) Correct the concentration of CerPCho 18:0 obtained by GC 
     29.9 nmol/ml X correction factor = corrected [CerPCho 18:0 (GC)] 
     29.9 nmol/ml X 2.48 = 74.2 nmol/ml 
4) Add corrected CerPCho 18:0 concentration to the PL 18:0 concentration to determine 
corrected total 18:0 concentration by GC. 
([18:0 (GC)] – [CerPCho 18:0 (GC)])+ corrected [CerPCho 18:0 (GC)] = corrected [18:0 
(GC)]  




Sphingomyelin fatty acids transesterification experiment 
An experiment was conducted to examine the extraction recovery of sphingomyelin fatty 
acids using two methods; namely the Lepage and Roy transesterification as used in the GC-
FID method and the new high throughput ESI-MS method. CerPCho 24:1 was selected and 
added to the synthetic PL mixture shown in table S5. The results are shown in table S6 and 
it clearly shows that 24:1 (sphingomyelin fatty acids) are not completely transesterified using 
the Lepage and Roy method as there was only a 45% recovery.  






GC-FID method  The high-throughput ESI-MS method 


















870.4 ± 17.3 
85.4 ± 0.5 
361.9 ± 6.4 
278.6 ± 4.6 
111.9  ± 5.4 
154.6 ±  17.3 








880.2 ± 11.9 
45.7 ± 1.0 
360.2 ± 3.7 
297.7 ± 6.2 
116.5  ± 1.9 
150.0 ± 5.8 









Footnote of abbreviations; * due to oxidation of PtdEtn (18:0/22:6) as described the expected 
concentration was 160 nmol/ml; 
#









Table S7: Targeted ion scans used to acquired phospholipid data. 
Lipid  Ion  Scan DP EP CE CXP  Mass range (Da)      
Head group scans 
PtdCho/CerPCho [M+H]+ PI 184.1 100 10 47  8 640-1000 
PtdEtn [M+H]+ NL141.0 100 10 30  8 685-950 
PtdSer [M+H]+ NL 185.0 100 10 30  8 755-965 
 
Fatty acyl chain scans 
16:1 [M-H]¯  PI 253.2 -100 -10 -55 -11 600-900 
16:0 [M-H]¯  PI 255.2 -100 -10 -55 -11 600-900 
17:0 [M-H]¯  PI 269.3 -100 -10 -55 -11 560-900 
18:2 [M-H]¯  PI 279.2 -100 -10 -40 -11 600-900 
18:1 [M-H]¯  PI 281.3 -100 -10 -55 -11 600-900 
18:0 [M-H]¯  PI 283.3 -100 -10 -55 -11 600-900 
19:0 [M-H]¯  PI 297.3 -100 -10 -55 -11 600-900 
20:5 [M-H]¯  PI 301.2 -100 -10 -40 -11 500-1000 
20:4 [M-H]¯  PI 303.2 -100 -10 -40 -11 600-1000 
20:3 [M-H]¯  PI 305.2 -100 -10 -40 -11 600-1000 
22:6 [M-H]¯  PI 327.2 -100 -10 -40 -11 700-1000 
22:5 [M-H]¯  PI 329.2 -100 -10 -40 -11 700-1000 
22:4 [M-H]¯  PI 331.2 -100 -10 -40 -11 700-1000 
24:0 [M-H]¯  PI 365.3 -100 -10 -40 -11 740-1040 
24:1 [M-H]¯  PI 363.3 -100 -10 -40 -11 740-1040 
Scan rate for positive ion mode was 200 Da/s, for negative ion mode 1000 Da/s. Mass shifting was 
prevented in negative ion mode by increasing number of summed scans. PI Precursor ion, NL neutral 
loss, DP declustering potential, EP entrance potential, CE collision energy, CXP collision cell exit 
potential. 
 
Table S8: Justification for Cost per sample for GC-FID method and ESI-MS method. 
Items GC-FID method ESI-MS method 
Materials and consumables $ 28.0  $ 10.0  
Maintenance contributions and initial cost $ 22.0  $ 10.0  







Table S9: Fatty acids concentrations (nmol/ml blood) in QC samples (n=57). Values are 





Mean ± SEM (%CV) 
16:0 454.3 ± 12.5 (13.4%) 
17:0 17.6 ± 1.1 (13.7%) 
18:0 257.7 ± 1.7 (8.3%) 
24:0 83.9 ± 1.3 (19.7%) 
16:1 4.4 ± 0.1 (14.9%) 
18:1 206.9 ± 10.9 (13.8%) 
24:1 104.0 ± 0.5 (7.5%) 
18:2 146.5 ± 3.3 (13.3) 
20:3 22.2 ± 0.3 (17.2%) 
20:4 187.9 ± 2.3 (10.0%) 
20:5 5.7 ± 0.1 (15.5%) 
22:4 21.7 ± 2.2 (17.9%) 
22:5 29.8 ± 1.2 (10.7%) 



















Figure S1: An example of spread sheet used to calculate the fatty acids levels from PL 
individual species detected from ESI-MS method.  
PL species Sample #1 Sample #2 Sample #3
PtdCho 16:0 -16:0 0.3067 0.4257 0.4061
PtdCho 16:0 -16:1 0.0529 0.0559 0.0840
PtdCho 16:0 -17:0 0.0223 0.0440 0.0404
PtdCho 16:0 -18:0 0.0670 0.1240 0.0692
PtdCho 16:0 -18:1 1.4029 1.9089 1.7042
PtdCho 16:0 -18:2 2.4135 2.5645 2.4609
PtdCho 17:0 -18:1 0.0577 0.0829 0.0991
PtdCho 17:0 -18:2 0.0571 0.1042 0.1010
PtdCho 18:0 -18:0 0.0218 0.0307 0.0192
PtdCho 18:0 -18:1 0.2411 0.3723 0.4016
PtdCho 18:0 -18:2 0.5075 0.7984 0.8687
PtdCho 18:1 -18:1 0.1741 0.2029 0.2515
PtdCho 18:1 -18:2 0.2553 0.3664 0.4422
PtdCho 16:0 -20:3 0.3944 0.2256 0.2142
PtdCho 16:0 -20:4 0.7541 0.9201 0.6681
PtdCho 16:0 -20:5 0.0323 0.0865 0.0774
PtdCho 18:0 -20:4 0.3001 0.4022 0.3045
PtdCho 18:1 -20:4 0.1172 0.1923 0.1533
PtdCho 16:0 -22:6 0.2240 0.3027 0.2285
PtdCho 18:0 -22:6 0.0488 0.0681 0.0758
PtdEtn 16:0 -18:1 0.9952 1.6980 1.1877
PtdEtn 16:0 -18:2 0.4094 0.5437 0.4861
PtdEtn 18:0 -18:0 0.0107 0.0206 0.0135
PtdEtn 18:0 -18:1 0.2436 0.2933 0.2676
PtdEtn 18:0 -18:2 0.2253 0.2728 0.2325
PtdEtn 18:1 -18:1 0.2107 0.3383 0.3201
PtdEtn 18:1 -18:2 0.2692 0.4544 0.4678
PtdEtn 16:0 -20:3 0.0805 0.0813 0.0891
PtdEtn 16:0 -20:4 0.6756 0.9784 0.6669
PtdEtn 16:0 -20:5 0.0391 0.0648 0.0584
PtdEtn 17:0 -20:4 0.1052 0.1373 0.1044
PtdEtn 17:0 -20:5   0.1183 0.1675 0.1294
PtdEtn 18:0 -20:4 0.4480 0.5038 0.4570
PtdEtn 16:0 -22:4 0.2259 0.2528 0.1547
PtdEtn 16:0 -22:5 0.1216 0.2065 0.1147
PtdEtn 18:1 -20:4 0.3976 0.5620 0.4405
PtdEtn 16:0 -22:6 0.3658 0.4774 0.3093
PtdEtn 17:0 -22:5 0.0595 0.0761 0.0590
PtdEtn 18:0 -22:6 0.1188 0.1370 0.1001
PtdSer 18:0 -18:0 0.0047 0.0056 0.0067
PtdSer 18:0 -18:1 0.2237 0.1789 0.2599
PtdSer 18:0 -20:4 1.3874 1.6430 1.6171
PtdSer 18:0 -22:5 0.2739 0.3720 0.2826
PtdSer 18:0 -22:6 0.4162 0.6404 0.4840
CerPCho 16:0 2.5708 3.6073 3.3175
CerPCho 18:0 0.3409 0.5706 0.4763
CerPCho 18:1 0.1172 0.2077 0.1788
CerPCho 24:0 2.5009 2.9584 2.0206
CerPCho 24:1 3.1676 4.1307 3.6350
Fatty acids Sample #1 Sample #2 Sample #3
16:0 11.5 15.0 12.7
16:1 0.1 0.1 0.1
17:0 0.4 0.6 0.5
18:0 4.9 6.5 6.0
18:1 4.7 6.8 6.3
18:2 4.1 5.1 5.1
20:3 0.5 0.3 0.3
20:4 4.2 5.3 4.4
20:5 0.2 0.3 0.3
22:4 0.2 0.3 0.2
22:5 0.5 0.7 0.5
22:6 1.2 1.6 1.2
24:0 2.5 3.0 2.0
24:1 3.2 4.1 3.6
Fatty acids Sample #1 Sample #2 Sample #3
16:0 458.4 599.7 509.7
16:1 2.1 2.2 3.4
17:0 16.8 24.5 21.3
18:0 196.7 259.6 239.0
18:1 187.7 273.5 252.2
18:2 165.5 204.2 202.4
20:3 19.0 12.3 12.1
20:4 167.4 213.6 176.5
20:5 7.6 12.8 10.6
22:4 9.0 10.1 6.2
22:5 18.2 26.2 18.3
22:6 46.9 65.0 47.9
24:0 100.0 118.3 80.8
24:1 126.7 165.2 145.4
Individual PL species 
concentration 
(nmol/10 uL of packed 
RBCs) determined by 
mass spectrometry as 
described in methods.
Individual fatty acid 
concentration 
(nmol/10 uL of packed 
RBCs) calculated 
from the sum of each 
individual PL species 
that contains that FA. 
If the PL contained 2 
moles of the FA, e.g. 
PtdCho 16:0-16:0 it 
was added twice.
To convert FA 
concentration from 
nmol/10 uL of packed 
RBCs to nmol/mL of 
blood the FA 
concentration obtained 
for 10 uL of packed 
RBCs was multiplied 
by 40 (x 100 to obtain 
mL of RBCs then x 0.4 
to convert to whole 




Testing solvents for lysing erythrocyte membranes 
a) The TRIS-Aliquot method 
In 2 mL glass vials, 10 µL of packed erythrocytes were added to 240 µL of TRIS-HCl. 
Following this, the tubes were vortexed for two minutes before a 25 µL aliquot was taken. 
The aliquot was dispensed into a new tube to which 75 µL of 200 mM ammonium acetate 
and 90 µL of methanol were added prior to a further 2 minutes of vortexing. Following this, 
300 µL of MTBE was added and tubes were vortexed again for 2 minutes after which they 
were left to stand for 1 minutes to allow phase separation. After phase separation had 
occurred, 300 µL of the upper lipid containing phase was removed and dried under nitrogen 
at 37oC. The dried lipid were then reconstituted to 150 µL using 2:1 methanol: chloroform 
and were stored at -20 oC until ready to be analysed. Prior to mass spectrometric analysis, 
extracts were diluted using 2:1 methanol: chloroform solution containing 5 mM ammonium 
acetate as spray solvent.  
b) Adding ammonium acetate first 
In 2 mL eppendorf tube, 10 uL of packed erythrocytes were added to 100 µL of an aqueous 
mixture containing 150 mM ammonium acetate and 2 mM EDTA before being vortexed. 
Following this, 100 µL of methanol was added and vortexed for 2 minutes. After that 400 µL 
of MTBE was added and vortexed for 2 minutes. 400 µL of the supernatant was removed 
and dried under nitrogen at 37oC and then reconstituted with 200 µL of 2:1 methanol: 
chloroform solution containing 5 mM ammonium acetate. Lipid extracts were stored at -20 oC 
until ready for analysis.  
c) TRIS-buffered ammonium chloride 
TRIS-buffered ammonium chloride was firstly optimised to PH 7.4 by the addition 
hydrochloric acid. As per methods above, 10 µL of packed erythrocytes were added to 100 
µL of the TRIS-buffered ammonium chloride and mixed by repeated aspirating/dispensing. 
The tubes were then vortexed for 2 minutes after which 120 µL of methanol was added 
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followed by further 2 minutes of vortexing. To each tube, 400 µL of MTBE was then added 
and each tube was again vortexed for 2 minutes. The upper phase was extracted, placed in 
a new glass vial and dried under nitrogen at 37oC and then reconstituted with 300 µL of 2:1 
methanol: chloroform and then stored at -20 oC until ready for analysis.  
d) Adding methanol first 
The method carried out was analogous to those previously described with some minor 
adjustments to reagent order and times for vortexing. Briefly, 10 µL of packed erythrocytes 
were added to 120 µL of methanol containing 0.01% BHT in eppendorf tubes and vortexed 
for 10 minutes. Following this, 400 µL of MTBE was added and the tubes underwent another 
10 minutes vortex before phase separation was initiated by addition 100 µL of 5 mM 
ammonium acetate. Lipid extracts were stored at -20 oC until ready for analysis.  
This study demonstrated that adding ammonium acetate as first reagent to packed 
erythrocytes produced quality mass spectra when analysed using ESI-MS. Having the 
erythrocytes suspended in aqueous mixture containing ammonium acetate and EDTA 
enable the methanol to interface more readily with the packed erythrocytes than if they were 
not in suspension. Further to this, the uniform solution created by suspending the packed 
erythrocytes in ammonium acetate and EDTA makes their analysis considerably more 
amenable to the robotic platform as the propensity of packed erythrocytes to clot is 
ameliorated. 
 
